Patient: Male, 29 FINAL DIAGNOSIS: Myopericarditis Symptoms: Chest pain Medication: Ibuprofen Clinical Procedure: - Specialty: Cardiology.
Objective: Unusual clinical course.
Background: Cannabis is the most commonly used illegal substance worldwide and its consumption portends significant side effects. Nowadays, in order to increase its psychotropic effect, various substances are being added constantly to it to promote its potency that might hold toxic effects to different organs including the heart and might lead to other unreported complications such as myopericarditis. Herein, we are presenting a unique case of recurrent myopericarditis after the consumption of contaminated marijuana, an association that has not been reported in literature before.
Case Report: A 29-year-old man presented to our institution with pressure-like left-sided chest pain that is aggravated by cough and deep inspiration and relieved by sitting and leaning forward. Examination revealed pericardial rub and workup showed elevated white blood cell count, C-reactive protein and troponin I level of 2.99 ng/ml. ECG upon admission showed ST-segment elevation in the inferior leads with PR-segment depression. Echocardiogram revealed only concentric hypertrophy. PATIENT was admitted to another institution with similar symptoms 2 months earlier. PATIENT admitted to using adulterated Marijuana on both occasions prior to hospitalization. Review of medical records from the outside hospital revealed similar ECG and laboratory findings. Treatment with Ibuprofen resulted in resolution of patient's symptoms and ECG abnormalities.
Conclusions: Recurrent myopericarditis in our patient is likely the result of consumption of contaminated Marijuana. Careful history taking in patients presenting with myopericarditis is crucial as it might be the causal link.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097 | PMC |
| http://dx.doi.org/10.12659/AJCR.889808 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- - Acute recurrent myopericarditis is a rare condition that occurs after a symptom-free period of 4-6 weeks, with no clear management guidelines, making it difficult to understand its causes and treatment.
- - A case study of a 44-year-old man showed he had recurrent myopericarditis caused by Coxsackie A virus, diagnosed through elevated biomarkers and pericardial effusion, and he improved with colchicine and ibuprofen.
- - The recurrence of myopericarditis can happen in 15%-50% of cases and is linked to various factors, but using current treatment methods for recurrent pericarditis has led to significant symptom relief, highlighting the need for more research into
MYOPERICARDITIS DUE TO COXIELLA BURNETII IN A TEENAGE MALE.
Pediatr Infect Dis J
November 2024
From the Division of Pediatric Infectious Diseases and Global Health, Department of Pediatrics, University of California San Francisco, San Francisco, San Francisco, California.
A 15-year-old male presented with acute chest pain and was diagnosed with myopericarditis due to acute Q fever, detected by cell-free DNA method. Despite taking a 2-week course of doxycycline, myopericarditis recurred after 6 months. In the absence of an alternative diagnosis, he began treatment for possible chronic Q fever with doxycycline and hydroxychloroquine and has not had further recurrence.
View Article and Find Full Text PDFMultiple recurrences of a left ventricular pseudoaneurysm: a case report.
Eur Heart J Case Rep
August 2024
Division of Cardiology, University of Louisville Heart Hospital, 201 Abraham Flexner Way, Suite 600, Louisville, KY 40202, USA.
Background: Takotsubo syndrome (TTS) is being diagnosed more often with its increased recognition over the past 2 decades and with the availability of imaging such as point-of-care echocardiography and tissue characterization by cardiovascular magnetic resonance (CMR).
Case Summary: A young man developed pericarditis and was treated with steroids. A few weeks later, he suffered classic TTS and then presented a week later with the rare complication of apical myocardial rupture and a left ventricular (LV) pseudoaneurysm.
Short- and long-term outcomes of cardiac adverse events following COVID-19 immunization managed in a Canadian pediatric center.
Vaccine
October 2024
Division of Cardiology, CHEO, University of Ottawa, Canada. Electronic address:
Article Synopsis
- The study focuses on pediatric patients who experienced cardiac adverse events following COVID-19 vaccination with Pfizer/BioNTech, specifically looking at cases from May 2021 to May 2022.
- Out of 17 male adolescents (average age 16), most cases of myopericarditis occurred after the 2nd or 3rd vaccine dose, with all patients showing improvement on anti-inflammatory medications.
- While all patients recovered, some reported negative impacts on their quality of life and developed vaccine hesitancy, emphasizing the need for effective follow-up and support for individuals who experience vaccine-related side effects.
Re-enforcing High-Risk Acute Pericarditis Requiring Hospital Admission: An Unusual Case of Critical Idiopathic Acute Pericarditis Presenting As Tamponade and Pleuro-Pericardial Complications in a Patient Presenting With Flu-Like Symptoms.
Cureus
April 2024
Pulmonary and Critical Care, Richmond University Medical Center, New York, USA.
Pericarditis is an inflammatory process that affects the pericardium, the fibrous sac surrounding the heart. Acute pericarditis accounts for approximately 0.1% of inpatient admissions and 5% of non-ischemic chest pain visits to the emergency departments (EDs).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!